EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Platelet Disorders and Medication Strategies

Zhao Zhang iD, Xianghui Zhou, Xiyuan Fang, Xin Zhou, Zhipeng Cheng, Yu Hu

Thrombosis and Haemostasis · 01.02.2026 · 126 (02) · 113-125

DOI: 10.1055/a-2561-8818 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Thrombosis and Haemostasis, erschienen am 01.02.2026. Verfasst von Zhao Zhang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, People's Republic of China. Hauptthemen laut MEDLINE: Blood Platelets, Blood Platelet Disorders, Platelet Aggregation Inhibitors, Thrombocytosis. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 131 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, National Key Research and Development Project of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Platelets are among the most abundant cells in the body and play important roles in coagulation and immunity. Platelets are formed when hematopoietic stem cells proliferate and differentiate into megakaryocytes via the regulation of various cytokines. After the megakaryocytes mature in the bone marrow cavity, proplatelets are released into the blood circulation where they eventually remodel into mature platelets. Given that the production and functions of platelets involve the regulation of many factors—such as hematopoietic stem cells, the hematopoietic microenvironment, and cytokines—the causes and mechanisms of platelet-related diseases are diverse, often involving platelet production, clearance, and distribution. In this review, we examined the regulation of platelet production and summarized common disorders affecting platelet quantity, namely, thrombocytopenia and thrombocytosis. In addition, we reviewed previous clinical studies and summarized the medication strategies commonly used for the treatment of different platelet disorders in different clinical scenarios.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Blood PlateletsBlood Platelet DisordersPlatelet Aggregation InhibitorsThrombocytosisThrombocytopeniaHumansCytokinesMegakaryocytesThrombopoiesisAnimals

Substanzen

Platelet Aggregation InhibitorsCytokines

Autor:innen und Institutionen

  • Department of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, People's Republic of China.
  • Department of Stomatology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, People's Republic of China.

ORCID-Profile: Zhao Zhang

Förderung

  • National Natural Science Foundation of China
  • National Key Research and Development Project of China

Zitieren

APA

Zhang, Z., Zhou, X., Fang, X., Zhou, X., Cheng, Z., & Hu, Y. (2026). Platelet Disorders and Medication Strategies. Thrombosis and Haemostasis, 126(02), 113-125. https://doi.org/10.1055/a-2561-8818

Vancouver

Zhang Z, Zhou X, Fang X, Zhou X, Cheng Z, Hu Y. Platelet Disorders and Medication Strategies. Thrombosis and Haemostasis. 2026;126(02):113-125. doi:10.1055/a-2561-8818

BibTeX
@article{Zhang2026,
  author = {Zhang, Zhao and Zhou, Xianghui and Fang, Xiyuan and Zhou, Xin and Cheng, Zhipeng and Hu, Yu},
  title = {Platelet Disorders and Medication Strategies},
  journal = {Thrombosis and Haemostasis},
  year = {2026},
  volume = {126},
  number = {02},
  pages = {113--125},
  doi = {10.1055/a-2561-8818}
}
Kostenlos starten →